Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fishman

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|September 10, 2005
Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinasesFeng-qiang Wang, John So, Scott Reierstad, et al.
Molecular Cancer Research : MCR|November 23, 2006
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasionFeng-Qiang Wang, Yoel Smicun, Nicholas Calluzzo, et al.
Cancer Biology & Therapy|April 8, 2010
Biomarkers for ovarian cancer detection and therapySonia Dutta, Feng-qiang Wang, Adrien Phalen, et al.
Gynecologic Oncology|October 20, 2004
Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8John So, Jason Navari, Feng-Qiang Wang, et al.
Gynecologic Oncology|January 22, 2005
Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosisYuru Meng, Shijun Kang, John So, et al.
FEBS Letters|December 27, 2005
Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentationShijun Kang, Rongcheng Luo, Yoel Smicun, et al.
Gynecologic Oncology|June 3, 2008
S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and RacKathleen M Devine, Yoel Smicun, Joanie Mayer Hope, et al.
Critical Reviews in Clinical Laboratory Sciences|October 20, 2006
The tumor microenvironment: key to early detectionEdgardo V Ariztia, Catherine J Lee, Radhika Gogoi, et al.
AJR. American Journal of Roentgenology|January 23, 2010
New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasoundSonia Dutta, Feng-qiang Wang, Arthur C Fleischer, et al.
Gynecologic Oncology|December 8, 2004
Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytesYuru Meng, Laura Graves, Thuy-Vy Do, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|September 10, 2005
Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinasesFeng-qiang Wang, John So, Scott Reierstad, et al.
Molecular Cancer Research : MCR|November 23, 2006
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasionFeng-Qiang Wang, Yoel Smicun, Nicholas Calluzzo, et al.
Cancer Biology & Therapy|April 8, 2010
Biomarkers for ovarian cancer detection and therapySonia Dutta, Feng-qiang Wang, Adrien Phalen, et al.
Gynecologic Oncology|October 20, 2004
Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8John So, Jason Navari, Feng-Qiang Wang, et al.
Gynecologic Oncology|January 22, 2005
Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosisYuru Meng, Shijun Kang, John So, et al.
FEBS Letters|December 27, 2005
Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentationShijun Kang, Rongcheng Luo, Yoel Smicun, et al.
Gynecologic Oncology|June 3, 2008
S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and RacKathleen M Devine, Yoel Smicun, Joanie Mayer Hope, et al.
Critical Reviews in Clinical Laboratory Sciences|October 20, 2006
The tumor microenvironment: key to early detectionEdgardo V Ariztia, Catherine J Lee, Radhika Gogoi, et al.
AJR. American Journal of Roentgenology|January 23, 2010
New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasoundSonia Dutta, Feng-qiang Wang, Arthur C Fleischer, et al.
Gynecologic Oncology|December 8, 2004
Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytesYuru Meng, Laura Graves, Thuy-Vy Do, et al.
Pageof 6